54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 08
11:33 UTC
|
PRMB
Primo Brands
|
◎ Target | Lauren Lieberman ★★★☆☆ #1047 | Overweight | $27.00→ $29.00+7.4% |
|
Aug 08
11:33 UTC
|
PRL
Propel
|
◎ Target | firm only | Buy | C$33.00→ C$37.00+12.1% |
|
Aug 08
11:33 UTC
|
PRL
Propel
|
◎ Target | firm only | Sec→ r Perform | C$27.00→ C$29.00+7.4% |
|
Aug 08
11:33 UTC
|
PRL
Propel
|
◎ Target | firm only | Buy | C$30.00→ C$34.00+13.3% |
|
Aug 08
11:33 UTC
|
PRL
Propel
|
◎ Target | firm only | Outperform | C$29.00→ C$38.00+31.0% |
|
Aug 08
11:33 UTC
|
PRL
Propel
|
◎ Target | firm only | Buy | C$34.00→ C$38.00+11.8% |
|
Aug 08
11:33 UTC
|
PPC
Pilgrim's Pride
|
◎ Target | Matheus Enfeldt not yet tracked | Neutral | $30.00→ $28.00-6.7% |
|
Aug 08
11:33 UTC
|
POU
Paramount Resources
|
◎ Target | firm only | Sec→ r Perform | C$35.00→ C$37.00+5.7% |
|
Aug 08
11:33 UTC
|
POU
Paramount Resources
|
◎ Target | firm only | Sec→ r Perform | C$34.00→ C$36.00+5.9% |
|
Aug 08
11:33 UTC
|
POU
Paramount Resources
|
◎ Target | firm only | Outperform | C$35.00→ C$37.00+5.7% |
|
Aug 08
11:33 UTC
|
POU
Paramount Resources
|
◎ Target | firm only | Outperform | C$35.00→ C$37.00+5.7% |
|
Aug 08
11:33 UTC
|
PLNT
Planet Fitness
|
◎ Target | Logan Reich ★★★☆☆ #1001 | Outperform | $70.00→ $65.00-7.1% |
|
Aug 08
11:33 UTC
|
PKOH
Park-Ohio
|
◎ Target | Steve Barger ★★☆☆☆ #2327 | Overweight | $45.00→ $59.00+31.1% |
|
Aug 08
11:33 UTC
|
PH
Parker-Hannifin
|
◎ Target | Jamie Cook ★★★☆☆ #1863 | Buy | $1,269.00→ $1,358.00+7.0% |
|
Aug 08
11:33 UTC
|
PH
Parker-Hannifin
|
◎ Target | Charles Minervino ★★☆☆☆ #2406 | Positive | $1,100.00→ $1,250.00+13.6% |
|
Aug 08
11:33 UTC
|
PH
Parker-Hannifin
|
◎ Target | Andrew Kaplowitz ★★★☆☆ #1330 | Buy | $1,141.00→ $1,232.00+8.0% |
|
Aug 08
11:33 UTC
|
PH
Parker-Hannifin
|
◎ Target | Jeffrey D. Hammond not yet tracked | Overweight | $1,100.00→ $1,210.00+10.0% |
|
Aug 08
11:33 UTC
|
PH
Parker-Hannifin
|
◎ Target | Amit Mehrotra ★★★☆☆ #2128 | Buy | $1,092.00→ $1,250.00+14.5% |
|
Aug 08
11:33 UTC
|
PFE
Pfizer
|
◎ Target | Vamil Divan ★★★★☆ #904 | Buy | $35.00→ $31.00-11.4% |
|
Aug 08
11:33 UTC
|
PENN
PENN Entertainment
|
◎ Target | Mike Hickey ★★☆☆☆ #2756 | Buy | $21.00→ $22.00+4.8% |
|
Aug 08
11:33 UTC
|
PCT
PureCycle Technologies
|
◎ Target | Andres Sheppard ★☆☆☆☆ #3145 | Overweight | $14.00→ $12.00-14.3% |
|
Aug 08
11:33 UTC
|
PBYI
Puma Biotechnology
|
◎ Target | Marc Frahm ★★☆☆☆ #2604 | Hold | $5.00→ $6.00+20.0% |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | Buy | C$117.00→ C$105.00-10.3% |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | Outperform | C$150.00→ C$130.00-13.3% |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | Buy | C$128.00→ C$127.00-0.8% |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | Sec→ r Perform | C$108.00→ C$98.00-9.3% |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | Sec→ r Outperform | C$110.00→ C$105.00-4.5% |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | Buy | C$120.00→ C$110.00-8.3% |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | Outperform | C$131.00→ C$120.00-8.4% |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | C$115.00→ C$100.00-13.0% | |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | C$123.00→ C$117.00-4.9% | |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | C$118.00→ C$111.00-5.9% | |
|
Aug 08
11:33 UTC
|
PBH
Premium Brands
|
◎ Target | firm only | Buy | C$140.00→ C$130.00-7.1% |
|
Aug 08
11:33 UTC
|
PAYC
Paycom Software
|
◎ Target | Steven Enders not yet tracked | Neutral | $136.00→ $194.00+42.6% |
|
Aug 08
11:33 UTC
|
PARR
Par Pacific
|
◎ Target | Jason Gabelman ★★★★☆ #536 | Buy | $100.00→ $95.00-5.0% |
|
Aug 08
11:33 UTC
|
PAR
PAR Technology
|
◎ Target | Andrew Harte ★★★☆☆ #1954 | Buy | $45.00→ $30.00-33.3% |
|
Aug 08
11:33 UTC
|
PAR
PAR Technology
|
◎ Target | Ella Smith ★★★★☆ #832 | Neutral | $17.00→ $18.00+5.9% |
|
Aug 08
11:33 UTC
|
OXY
Occidental Petroleum
|
◎ Target | Sam Margolin ★★★★☆ #680 | Overweight | $72.00→ $79.00+9.7% |
|
Aug 08
11:33 UTC
|
OTF
Blue Owl Technology Finance
|
◎ Target | Chris Muller ★★★☆☆ #1974 | Market Outperform | $16.00→ $17.00+6.2% |
|
Aug 08
11:33 UTC
|
OTEX
Open Text
|
◎ Target | Steven Enders not yet tracked | Neutral | $25.00→ $28.00+12.0% |
|
Aug 08
11:33 UTC
|
OTEX
Open Text
|
◎ Target | firm only | Sec→ r Outperform | $40.00→ $33.00-17.5% |
|
Aug 08
11:33 UTC
|
OTEX
Open Text
|
◎ Target | Seth Gilbert not yet tracked | Neutral | $25.00→ $27.00+8.0% |
|
Aug 08
11:33 UTC
|
OSCR
Oscar Health
|
◎ Target | Jonathan Yong ★☆☆☆☆ #2997 | Neutral | $20.00→ $26.00+30.0% |
|
Aug 08
11:33 UTC
|
ORGO
Organogenesis
|
◎ Target | Ravi Misra not yet tracked | Hold | $3.00→ $2.00-33.3% |
|
Aug 08
11:33 UTC
|
ORA
Ormat Technologies
|
◎ Target | Noah Kaye ★★★☆☆ #2110 | Outperform | $144.00→ $141.00-2.1% |
|
Aug 08
11:33 UTC
|
ONTO
Onto Innovation
|
◎ Target | Charles Shi ★☆☆☆☆ #3060 | Buy | $330.00→ $360.00+9.1% |
|
Aug 08
11:33 UTC
|
ONTO
Onto Innovation
|
◎ Target | Blayne Curtis ★★☆☆☆ #2843 | Buy | $350.00→ $400.00+14.3% |
|
Aug 08
11:33 UTC
|
ONT
Montrose Environmental Group
|
◎ Target | James Ricchiuti ★★☆☆☆ #2559 | Buy | $28.00→ $23.00-17.9% |
|
Aug 08
11:33 UTC
|
OFRM
Once Upon A Farm
|
◎ Target | Thomas Palmer ★★★☆☆ #1710 | Overweight | $22.00→ $26.00+18.2% |
|
Aug 08
11:33 UTC
|
OEC
Orion
|
◎ Target | Joshua Spector ★★★☆☆ #1604 | Neutral | $7.50→ $8.00+6.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.